Market closedNon-fractional
Kenvue /KVUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Kenvue
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Ticker
KVUE
Sector
Consumer Non-Cyclicals
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Skillman, United States
Employees
22,000
Website
www.kenvue.com
Kenvue Metrics
BasicAdvanced
$35B
Market cap
23.29
P/E ratio
$0.78
EPS
-
Beta
$0.60
Dividend rate
3.29%
Dividend yield
Price and volume
Market cap
$35B
Dividend rate
$0.60
Financial strength
Current ratio
0.989
Quick ratio
0.538
Long term debt to equity
67.141
Total debt to equity
81.885
Dividend payout ratio (TTM)
1,001.81%
Interest coverage (TTM)
6.52%
Management effectiveness
Return on assets (TTM)
5.91%
Return on equity (TTM)
9.65%
Valuation
Price to earnings (TTM)
23.288
Price to revenue (TTM)
2.234
Price to book
3.12
Price to tangible book (TTM)
-4.55
Price to free cash flow (TTM)
16.587
Dividend yield (TTM)
3.29%
Growth
Revenue change (TTM)
1.80%
Earnings per share change (TTM)
-20.56%
What the Analysts think about Kenvue
Analyst Ratings
Majority rating from 16 analysts.
Kenvue Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.9B
6.22%
Net income
$296M
-9.48%
Profit margin
7.60%
-14.70%
Kenvue Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.32
$0.31
$0.31
$0.28
-
Expected
$0.30
$0.31
$0.28
$0.26
$0.28
Surprise
5.96%
-1.00%
10.66%
9.63%
-
Kenvue News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Aug
14
Kenvue
Dividend·Ex-dividend
Aug
28
Kenvue
Dividend·Payment
$0.205
Per share
FAQs
What’s the current market cap for Kenvue stock?
Kenvue (KVUE) has a market cap of $35B as of July 27, 2024.
What is the P/E ratio for Kenvue stock?
The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 23.29 as of July 27, 2024.
Does Kenvue stock pay dividends?
Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.6 and the yield is 3.29%. Kenvue has a payout ratio of 1001.81% on a trailing twelve-month basis.
When is the next Kenvue dividend payment date?
The next Kenvue (KVUE) dividend payment is scheduled for August 28, 2024.
What is the beta indicator for Kenvue ?
Kenvue (KVUE) does not currently have a Beta indicator.
Buy or sell Kenvue stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.